about
The IKK complex contributes to the induction of autophagyAutophagy-dependent anticancer immune responses induced by chemotherapeutic agents in miceSpermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome.Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy.Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.IKK connects autophagy to major stress pathways.A new frontier in synthetic biology: automated design of small RNA devices in bacteria.Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity.An immunosurveillance mechanism controls cancer cell ploidy.Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.Autophagic removal of micronuclei.p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200.Negative regulation of interferon-γ/STAT1 signaling through cell adhesion and cell density-dependent STAT1 dephosphorylation.A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1.Defective autophagy associated with LC3 puncta in epothilone-resistant cancer cells.17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.Dynamic signal processing by ribozyme-mediated RNA circuits to control gene expression.Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39.Theoretical and experimental analysis of the forced LacI-AraC oscillator with a minimal gene regulatory model.Model-based design of RNA hybridization networks implemented in living cells.Longevity-relevant regulation of autophagy at the level of the acetylproteome.Prognostic Impact of Vitamin B6 Metabolism in Lung CancerTranslational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanomaPremortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathThe end of autophagic cell death?An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cellsEmerging role of mRNA epitranscriptomic regulation in chemoresistant cancer cells
P50
Q24329117-89B8D16B-8A63-4DE6-A35D-7253629DE70CQ29615615-BF28C8BD-3FB9-449B-8E5C-ADD63675825BQ34600785-BA267A3A-A1A4-4321-A074-2A5E639520DFQ36662373-9A36521D-63CF-4339-A8F3-505A93025EE4Q36850338-A67E7353-BAC5-48A6-B668-D9E17ECD1B5EQ37683307-6CDCD3E9-853B-429C-B099-D491D9D33909Q38124571-0CF55D16-3770-4D49-B5A3-5A3D371FA648Q39256099-6D3C2E42-2468-412B-8D1C-F7F78F5ADABAQ39269872-760620B6-6AA3-48F3-8227-89360FA66A80Q39311553-40C7FB1D-210A-4133-99AE-96D46A8619A7Q39425124-6DDDE082-A437-4BE2-842F-74EDBE43AAD7Q39503431-4CA70585-1484-4D48-99F5-A249DC2B98E5Q39555079-47EFCA9C-CC62-4BB2-93FC-E542691C1FE0Q39565425-ADA7CE3F-1E9F-4400-A4E1-08D2AFA49E90Q39761225-08F91712-5BD2-4C60-8063-EE5B58588ED7Q39808290-83071522-25CA-44CA-90FF-B94CE2119CBBQ41193950-D7D0EE19-CB05-49D6-A59D-74B3714B3FCDQ42138273-47A649D3-BEDE-41D4-9A8A-4D9C28750555Q46716097-3D3162DC-C06E-439B-8D2A-9CA7C0667494Q47651103-F0FDEABF-E3D5-4E2C-A4A4-0BD7E031B391Q52718271-2D5272E8-C48F-4EE2-A85B-ED531A53F51AQ57832558-D4B9FDC9-1487-4FD6-A006-CA3138636008Q58105812-C0A674A1-DB07-40C0-85CA-83BE0F9FE183Q61053617-C407F624-815F-4DBD-8E8F-5D9FB6D9D47CQ82502055-5CCAA511-0737-40A3-A366-F0DA1C396B6BQ92024362-E70D8FD9-A785-4378-83B1-19F04EC3E8D0Q94547783-0B4E2E61-0F23-41ED-AF0E-4AD262F34363
P50
description
researcher ORCID ID = 0000-0002-5087-8220
@en
wetenschapper
@nl
name
Shensi Shen
@ast
Shensi Shen
@en
Shensi Shen
@es
Shensi Shen
@nl
type
label
Shensi Shen
@ast
Shensi Shen
@en
Shensi Shen
@es
Shensi Shen
@nl
prefLabel
Shensi Shen
@ast
Shensi Shen
@en
Shensi Shen
@es
Shensi Shen
@nl
P106
P31
P496
0000-0002-5087-8220